009420.KS Overview

Company Profile

Related stocks

068760.KQ • South Korea

Celltrionph

38,800 KRW

1.28B USD 1Y -27.1%

006280.KS • South Korea

GC Biopharma Corp.

129,400 KRW

1.1B USD 1Y -2.2%

4540.T • Japan

TSUMURA & CO

3,772 JPY

1.78B USD 1Y +5%

4516.T • Japan

NIPPON SHINYAKU CO

3,372 JPY

1.44B USD 1Y -0.4%

195940.KQ • South Korea

HK inno.N

39,700 KRW

839.31M USD 1Y -13.3%

4887.T • Japan

SAWAI GROUP HOLDINGS CO LTD

1,629.5 JPY

1.19B USD 1Y -18.6%

688321.SS • China

SHENZHEN CHIPSCREEN BIOSCIENCES

24.31 CNY

1.61B USD 1Y -23.6%

COHANCE.NS • India

COHANCE LIFESCIENCES LTD

441 INR

1.74B USD 1Y -48.6%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile

4 Metrics

Country

South Korea

Region

Asia-Pacific

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High

5Y Volatility

64.7% p.a.

Max Drawdown (5Y)

-51.3%

Sharpe Ratio (5Y)

0.23

Beta Factor

0.93

Size Class

Mega Cap

Notes & Warnings

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).

Exemplary balance sheet strength: Very solid ratio of equity to debt.

🔴 High valuation risk: Avg P/E of 376.9 (Elevated multiple compression risk)

🔴 Low analyst coverage – higher uncertainty in growth estimates & projections

Elevated Short-Term Volatility: 3Y volatility (73.1%) is noticeably higher than the 5Y average (64.7%).

Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (64.7% p.a.).

Historical Stress Test: Maximum peak-to-trough drawdown of -69.5% in the extended horizon.